Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04914611 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real World Assessment of People Living With Chronic Hepatitis B in Australia

Study acronym: REACH-B
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jul 1, 2026 to Jul 31, 2030
    • Study completion date: Jul 1, 2027 to Jul 31, 2030
    • Site details revised at 1 of 19 sites
    v8
  2. Site details revised at 6 of 19 sitesv7
  3. Study sites: 1 to 19v6
  4. Re-verified, no change to tracked fieldsv5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 1, 2022 to Feb 17, 2022
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Oct 1, 2021 to Jan 1, 2022v3
  2. Start date: Jul 1, 2021 to Oct 1, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The REACH-B study establishes an observational cohort study of people living with chronic hepatitis B from a national network, including a diverse range of services, to characterise and monitor hepatitis B linkage to care and treatment requirements amongst this population.
Trial Details
NCT Number NCT04914611
Lead Sponsor Kirby Institute
Conditions
(from sponsor)		 Hepatitis B
Related terms Hepatitis B
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov